Today, the CSO of XBiotech (XBIT), Sushma Shivaswamy, bought shares of XBIT for $11.25K.
This recent transaction increases Sushma Shivaswamy’s holding in the company by 100%. In addition to Sushma Shivaswamy, 2 other XBIT executives reported Buy trades in the last month.
See today’s analyst top recommended stocks >>
Currently, XBiotech has an average volume of 209.8K.
In the last 30 days, insiders have sold $45K worth of XBIT shares and purchased $1.42M worth of XBIT shares. The insider sentiment on XBiotech has been positive according to 15 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
XBiotech, Inc. is a biopharmaceutical company, which engages in discovering and developing True Human monoclonal antibodies for treating diseases. It offers MABp1, which targets and neutralizes interleukin-1 alpha, a molecule known to promote angiogenesis, growth and spread of tumors, as well as mediate symptoms such as metabolic dysregulation, fatigue, and anxiety associated with advanced cancer. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.
